Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The study will assess the regression of yellow plaque content of the lipid pool after
aggressive lipid therapy by utilizing NIR spectroscopy. Statin therapy using Rosuvastatin
10-40 mg will be compared to the statin therapy of either Atorvastatin or Simvastatin. This
is a single site study. A total of 100 subjects will randomized, of which 40 will receive
intensive lipid therapy (Rosuvastatin 40mg) and 40 will receive standard care lipid lowering
therapy.